To evaluate the combined impact of fasting plasma glucose and serum uric acid on the severity of peripheral diabetic retinopathy in patients with type 2 diabetes mellitus.
Developed a nomogram for risk assessment
Analyzed fasting plasma glucose and serum uric acid levels
Examined association with diabetic retinopathy severity
Identified significant interaction between fasting plasma glucose and serum uric acid
Demonstrated risk stratification for peripheral diabetic retinopathy
Proposed targeted clinical management to prevent complications.
Abstract
The validated nomogram enables personalized risk stratification, guiding targeted clinical management to prevent vision-threatening DR complications.